Spoken Alpha
OMCL
OMNICELL, INC.
Overview
Omnicell provides medication management automation systems and software to hospitals, health systems, and pharmacies across inpatient, outpatient, and retail settings.
OMNICELL, INC is a Healthcare company operating in Health Information Services with a $1.78B market cap.
Most recent reported earnings: Q2 FY2026 (Jul 29, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-04-288 Q&A exchanges
- Q4 FY2025Earnings2026-02-0527 Q&A exchanges
- Q3 FY2025Earnings2025-10-3015 Q&A exchanges
- Q2 FY2025Earnings2025-08-0111 Q&A exchanges
- Q1 FY2025Earnings2025-05-0621 Q&A exchanges
- Q4 FY2024Earnings2025-02-0624 Q&A exchanges
- Q3 FY2024Earnings2024-10-3030 Q&A exchanges
- Q2 FY2024Earnings2024-08-0432 Q&A exchanges
- Q1 FY2024Earnings2024-05-0224 Q&A exchanges
- Q4 FY2023Earnings2024-02-0835 Q&A exchanges
- Q3 FY2023Earnings2023-11-0523 Q&A exchanges
- Q2 FY2023Earnings2023-08-0127 Q&A exchanges
- Q1 FY2023Earnings2023-05-0218 Q&A exchanges
- Q4 FY2022Earnings2023-02-2837 Q&A exchanges
- Q3 FY2022Earnings2022-11-0229 Q&A exchanges
- Q2 FY2022Earnings2022-08-0717 Q&A exchanges
- Q1 FY2022Earnings2022-04-3019 Q&A exchanges
- Q4 FY2021Earnings2022-02-1531 Q&A exchanges
- Q3 FY2021Earnings2021-11-0222 Q&A exchanges
- Q2 FY2021Earnings2021-07-3133 Q&A exchanges
- Q1 FY2021Earnings2021-05-0122 Q&A exchanges
History
Earnings history
- Q2 FY20262026-07-29EPS— vs $0.47—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-07-29 | — | $0.47 | — | — | — | — | EODHD |
Source: EODHD. OMCL reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks OMCL's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.73 | $2.83 | +31.9% | -3.7% | -4.7% |
| Q4 FY2026 | $3.82 | $2.92 | +30.8% | +1.4% | +1.2% |
| Q3 FY2026 | $4.06 | $2.95 | +37.7% | +3.6% | +4.9% |
| Q2 FY2026 | $3.45 | $2.71 | +27.4% | +6.6% | +9.6% |
| Q1 FY2025 | $3.52 | $2.73 | +28.9% | +6.3% | +7.4% |
| Q4 FY2025 | $3.62 | $2.87 | +26.0% | +4.2% | +3.4% |
| Q3 FY2025 | $3.73 | $2.86 | +30.3% | +0.2% | +2.9% |
| Q2 FY2025 | $3.86 | $3.08 | +25.3% | +1.0% | +0.6% |
| Q1 FY2024 | $3.94 | $2.97 | +32.8% | +6.1% | +3.6% |
| Q4 FY2024 | $4.16 | $3.05 | +36.4% | -0.9% | -1.5% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Randall A LippsCEO1 yr21 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Harlan Baird RadfordCFO10 mono recorded callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Nchacha EttaCFO10 mo9 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
- Nnamdi NjokuCOO7 mo3 callsCurrentSample
COO since 2025 • 2/4 beats (50%) • last call held guidance Q3 FY2026
- Brian H NuttVP, Chief Accounting Officer10 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance raise Q2 FY2026
- Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER1 yr 1 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for OMCL.
$ curl https://api.spokenalpha.com/v1/companies/OMCLFAQ
Frequently asked about OMCL
Where can I find OMNICELL, INC.'s (OMCL) earnings call transcripts?
Spoken Alpha indexes OMCL's earnings call transcripts at https://spokenalpha.com/companies/OMCL. Each call links to attributed speakers and parsed analyst Q&A. OMNICELL, INC.'s own investor relations page is at https://ir.omnicell.com/overview/default.aspx.
When was OMNICELL, INC.'s most recent earnings call?
OMNICELL, INC. (OMCL) held its most recent earnings call on 2026-04-28, covering fiscal Q1 2026.
What sector is OMCL in?
OMNICELL, INC. (OMCL) operates in the Healthcare sector (Health Information Services industry).